- Home
- PHVS vs PARR Comparison
PHVS vs PARR Comparison
Compare PHVS & PARR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHVS
- PARR
- Stock Information
- Founded
- PHVS 2015
- PARR 1984
- Country
- PHVS Netherlands
- PARR United States
- Employees
- PHVS N/A
- PARR N/A
- Industry
- PHVS Biotechnology: Pharmaceutical Preparations
- PARR Integrated oil Companies
- Sector
- PHVS Health Care
- PARR Energy
- Exchange
- PHVS Nasdaq
- PARR Nasdaq
- Market Cap
- PHVS 1.0B
- PARR 971.9M
- IPO Year
- PHVS 2021
- PARR N/A
- Fundamental
- Price
- PHVS $17.11
- PARR $17.74
- Analyst Decision
- PHVS Strong Buy
- PARR Buy
- Analyst Count
- PHVS 5
- PARR 7
- Target Price
- PHVS $41.60
- PARR $24.14
- AVG Volume (30 Days)
- PHVS 49.2K
- PARR 835.4K
- Earning Date
- PHVS 11-13-2024
- PARR 02-25-2025
- Dividend Yield
- PHVS N/A
- PARR N/A
- EPS Growth
- PHVS N/A
- PARR N/A
- EPS
- PHVS N/A
- PARR 5.32
- Revenue
- PHVS N/A
- PARR $8,325,746,999.00
- Revenue This Year
- PHVS N/A
- PARR N/A
- Revenue Next Year
- PHVS N/A
- PARR N/A
- P/E Ratio
- PHVS N/A
- PARR $3.31
- Revenue Growth
- PHVS N/A
- PARR 5.96
- 52 Week Low
- PHVS $15.21
- PARR $14.84
- 52 Week High
- PHVS $33.00
- PARR $40.70
- Technical
- Relative Strength Index (RSI)
- PHVS 38.75
- PARR 55.64
- Support Level
- PHVS $17.11
- PARR $16.22
- Resistance Level
- PHVS $18.70
- PARR $17.86
- Average True Range (ATR)
- PHVS 1.10
- PARR 0.80
- MACD
- PHVS -0.07
- PARR -0.07
- Stochastic Oscillator
- PHVS 34.65
- PARR 65.24
About PHVS Pharvaris N.V.
Pharvaris NV is a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to prevent and treat HAE attacks. By directly pursuing this clinically therapeutic target with novel small molecules, With positive data in both Phase 2 prophylaxis and studies in HAE, Pharvaris is developing deucrictibant. Pharvaris is currently enrolling a pivotal Phase 3 study for the treatment of HAE attacks and plans to initiate a pivotal Phase 3 study of deucrictibant for the prevention of HAE attacks.
About PARR Par Pacific Holdings Inc.
Par Pacific Holdings Inc is an oil and gas company that manages and maintains interests in energy and infrastructure businesses. The company has three reportable segments namely Refining, Under its refining business, the company produces ultra-low-sulfur diesel, gasoline, jet fuel, marine fuel, LSFO, and other associated refined products. Its Retail includes operation licenses out brands to serve the retail consumer. Through the Logistics segment, crude shipments are delivered to the refineries, in addition to finished products that are exported. It generates maximum revenue from the Refining segment.